회사 개요
The Joint Corp. (JYNT) operates as a franchisor and operator within the United States, providing comprehensive services for chiropractic clinics that include franchisee training, site selection, construction and vendor management, and ongoing operational support. This business model places the company firmly within the Healthcare sector, specifically under the Medical Care Facilities industry, where it leverages a specialized network to deliver patient care services. The enterprise currently maintains a market capitalization of $126.33M and employs 202 individuals to support its franchise and operational activities. With a trailing twelve-month revenue of $54.90M, the company's financial scale reflects a mid-cap position in the specialized medical care segment, indicating a focused operational footprint rather than broad diversification. The valuation metrics suggest that the market values the company at a premium relative to its book value, which is characteristic of businesses with high gross margins and specialized service capabilities in the healthcare infrastructure space.
재무 건전성
The company reported a revenue of $54.90M over the trailing twelve months, yet recorded a net income of $-268,157, revealing a significant gap between top-line generation and bottom-line profitability that points to substantial cost structures or one-time expenses affecting the reported earnings. Despite the negative net income, the entity generated an EBITDA of $738,683, indicating that operating cash generation remains positive even when accounting for non-cash items and interest expenses. The free cash flow stands at $5.97M, which provides the company with essential financial flexibility to fund operations, maintain its franchise network, or potentially pursue strategic acquisitions without relying heavily on external financing. Profitability analysis shows a gross margin of 79.6%, demonstrating strong pricing power or low cost of goods sold typical in service-based medical franchises, while the operating margin sits at 4.2% and the profit margin at 5.3%, reflecting the thin margins often found in capital-intensive or labor-intensive healthcare facility operations. On the balance sheet, the company holds $23.60M in cash against only $2.01M in debt, resulting in a debt-to-equity ratio of 13.33, which suggests a highly conservative leverage position despite the low absolute debt levels. Liquidity is robust with a current ratio of 1.59, ensuring the company can comfortably meet its short-term obligations. Return on Equity is recorded at -1.5% and Return on Assets at -0.8%, metrics that reveal management has yet to convert the substantial asset base and equity capital into positive shareholder returns in the current reporting period.
밸류에이션 평가
The valuation metrics present a complex picture, with a forward P/E of 39.20 and a trailing P/E ratio listed as N/A, implying that the market is pricing in significant future earnings growth to justify the current share price since historical earnings are currently negative. The price-to-book ratio is 8.29, indicating that the stock trades at a substantial premium to its book value, which often occurs in sectors where intangible assets like brand reputation and franchise agreements drive value more than physical assets. Alternative valuation measures such as the price-to-sales ratio of 2.30 and an EV/EBITDA of 139.33 further highlight that the market is willing to pay a high multiple for the company's sales and earnings power, anticipating a rapid turnaround or expansion in future periods. The stock has exhibited volatility within a 52-week range bounded by a high of $13.47 and a low of $7.50, with the current trading price situated relative to this range reflecting investor sentiment toward the company's turnaround potential. The beta value of 1.23 indicates that the stock's price volatility is 23% higher than the broader market, suggesting that JYNT is more sensitive to market fluctuations than large-cap healthcare peers.
Growth & Income
The growth profile is characterized by a revenue growth of 3.1% year-over-year and an earnings growth of 6276.7% year-over-year, where the massive earnings expansion is a mathematical artifact of moving from a small negative base rather than traditional organic earnings growth. Since the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, the firm retains all earnings to reinvest into business growth, franchise expansion, or operational improvements rather than distributing cash to shareholders. The absence of a dividend program aligns with the company's current stage of development where capital is prioritized for operational scaling and franchisee support rather than income generation. Overall, the growth and income profile suggests a high-risk, high-reward trajectory where investors are compensated for risk through potential capital appreciation rather than yield, relying on the eventual normalization of earnings to support future payout capabilities.